| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.94B | 12.62B | 13.18B | 8.51B | 19.08B | 18.74B |
| Gross Profit | 13.94B | 12.62B | 13.18B | 8.51B | 19.08B | 18.74B |
| EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 1.33B | 1.58B | 1.17B | 1.63B | 3.28B | 1.90B |
Balance Sheet | ||||||
| Total Assets | 206.11B | 210.38B | 208.94B | 217.11B | 251.59B | 263.74B |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 112.98B | 118.31B | 88.56B | 114.81B | 130.56B |
| Total Debt | 13.08B | 11.53B | 14.10B | 15.40B | 12.24B | 11.95B |
| Total Liabilities | 184.38B | 188.72B | 187.82B | 199.28B | 216.67B | 224.97B |
| Stockholders Equity | 21.64B | 21.57B | 19.62B | 17.77B | 34.65B | 38.49B |
Cash Flow | ||||||
| Free Cash Flow | 249.00M | -401.00M | 62.00M | -8.22B | -2.64B | 6.95B |
| Operating Cash Flow | 249.00M | -401.00M | 62.00M | -8.18B | -2.59B | 7.00B |
| Investing Cash Flow | 1.10B | 2.56B | 4.53B | 6.08B | -1.83B | 550.00M |
| Financing Cash Flow | -393.00M | -3.41B | -2.99B | 1.76B | -741.00M | -1.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | €12.27B | 7.12 | 11.85% | 2.07% | 2.01% | 79.48% | |
74 Outperform | €22.00B | 9.70 | 9.85% | 4.43% | -12.70% | -12.34% | |
68 Neutral | €15.46B | 12.78 | 6.47% | 5.67% | -15.54% | 10.53% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | €12.05B | 11.16 | 12.65% | 5.55% | 16.35% | 67.44% | |
63 Neutral | €10.35B | 7.89 | 14.93% | 5.47% | -6.64% | ― | |
61 Neutral | €65.65B | 11.00 | 12.05% | 5.46% | 0.12% | -2.71% |